MarketCap
Facebook
X
Telegram
Profound Medical Corp. Balance Sheet 2025-2011 | PROF
Brief balance sheet overview of Profound Medical Corp.
The comparison uses five available annual reports from the 2021–2025 interval.
Assets finished at $77.5 million versus $86.8 million initially, losing -10.7%. The balance sheet contracted.
Liabilities expanded faster than the asset base, +79.3% versus -10.7%. Debt-service capacity deserves attention.
The equity ratio reached 85.7% from . A high capital share reduces dependence on liabilities.
Negative net debt of -$55 million means cash holdings are larger than debt obligations.
Cash accounts for 77.1% of assets versus 77.4% initially. The change indicates the degree of financial flexibility.
Retained earnings are negative at -$287.7 million. This reduces the formal capital cushion, although large shareholder returns may have contributed.
Conclusion
Profound Medical Corp. retains a reasonably healthy balance sheet structure, which still needs support from earnings and cash flow.
Annual Balance Sheet Profound Medical Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-55 M | -51.7 M | -21 M | -39.1 M | - | - | -7.36 M | -18.7 M | -5.96 M | -10.6 M | -3.37 M | 1.31 M | - | - | - |
Long Term Debt |
4.5 M | 2.92 M | 5 M | 7.17 M | - | - | 6.72 M | 10.6 M | 444 K | 2.8 M | 4.01 M | 1.95 M | - | - | - |
Long Term Debt Current |
213 K | 257 K | 259 K | 239 K | 250 K | 312 K | 199 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 2.44 M | 9.69 M | 12 M | 3.01 M | 2.91 M | 4.29 M | - | - | - | - |
Total Current Liabilities |
6.08 M | 6.56 M | 6.37 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
11 M | 9.81 M | 12.7 M | 12.4 M | 6.16 M | 7.25 M | - | - | 13.7 M | 6.59 M | 5.21 M | 103 K | - | - | - |
Deferred Revenue |
445 K | 419 K | 721 K | - | - | 358 K | 655 K | 313 K | 241 K | 193 K | - | - | - | - | - |
Retained Earnings |
-288 M | -245 M | -217 M | -189 M | - | -130 M | -131 M | -111 M | -90.3 M | -53.2 M | -39.7 M | -453 K | - | - | - |
Total Assets |
77.5 M | 70.2 M | 44 M | 64.4 M | 86.8 M | 105 M | - | - | 27.9 M | 17.6 M | 15.3 M | 1.47 M | - | - | - |
Cash and Cash Equivalents |
59.7 M | 54.9 M | 26.2 M | 46.5 M | 67.2 M | 83.9 M | 14.8 M | - | - | - | - | - | - | - | - |
Book Value |
66.4 M | 60.4 M | 31.2 M | 52 M | 80.6 M | 97.4 M | - | - | 14.1 M | 11 M | 10.1 M | 1.37 M | - | - | - |
Total Shareholders Equity |
66.4 M | 60.4 M | 31.2 M | 52.6 M | - | 97.4 M | 14.4 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Profound Medical Corp.
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2023-Q4 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
4.5 M | 2.92 M | 4.46 M | 4.49 M | 578 K | - | - | - | - | 1.13 M | - | - | - | 1.36 M | - | - | - | 1.64 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
14 M | 10.2 M | 10.4 M | 10.1 M | 12.7 M | - | - | - | - | 6.16 M | - | - | - | 7.25 M | - | - | - | 15.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
464 K | 434 K | 694 K | 636 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-295 M | -280 M | -272 M | -256 M | -218 M | - | - | - | - | -161 M | - | - | - | -130 M | - | - | - | -108 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
73.5 M | 42.3 M | 49.7 M | 60.9 M | 43.9 M | - | - | - | - | 86.8 M | - | - | - | 105 M | - | - | - | 30.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
50.3 M | 24.8 M | 35.2 M | 46.4 M | 26.2 M | - | - | - | - | 67.2 M | - | - | - | 83.9 M | - | - | - | 14.8 M | - | - | - | 22.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
59.4 M | 32.1 M | 39.3 M | 50.8 M | 31.2 M | - | - | - | - | 80.6 M | - | - | - | 97.4 M | - | - | - | 14.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
59.4 M | 32.1 M | 39.3 M | 50.8 M | 31.2 M | - | - | - | - | 80.6 M | - | - | - | 97.4 M | - | - | - | 14.4 M | - | - | - | 19.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Balance Sheet is a fundamental financial report of Profound Medical Corp., providing a complete picture of the company’s financial position at a specific point in time. Unlike the income statement, which records the results of operations over a certain period, the balance sheet shows what assets the company owns, what liabilities it has to creditors, and what equity is available to the owners.
For an investor, the balance sheet is important because it allows assessing the company’s financial stability, understanding how much debt it carries, and how dependent it is on borrowed financing. It helps calculate key liquidity and leverage ratios. When analyzing, attention should be paid to the debt-to-equity ratio (Debt/Equity), the amount of cash on the balance sheet, and the ratio of current liabilities to liquid assets.
Features of balance sheet analysis- Vertical and horizontal analysis
Vertical analysis shows the structure of the balance sheet as a percentage of total assets or liabilities, while horizontal analysis shows the dynamics of changes over multiple periods. - Asset quality
It is important to evaluate not only the amount of assets but also their liquidity and realizability. - Accounting for off-balance sheet liabilities
Some liabilities may not be directly reflected in the balance sheet, which requires additional attention.
USA
France
China
Israel
Canada
